Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Net Lease Office Properties When Issued | NLOP | Nov 27, 2024 | 32.12 | +2.49 |
Net Power A | NPWR | Nov 27, 2024 | 12.99 | +4.34 |
NetApp | NTAP | Nov 27, 2024 | 122.43 | -5.53 |
Netcapital | NCPL | Nov 27, 2024 | 1.88 | -3.59 |
NetEase ADR | NTES | Nov 27, 2024 | 86.56 | +0.41 |
Netflix | NFLX | Nov 27, 2024 | 877.34 | +0.54 |
NETGEAR | NTGR | Nov 27, 2024 | 24.04 | -4.11 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Nov 27, 2024 | 45.02 | +0.63 |
NetScout Systems | NTCT | Nov 27, 2024 | 22.02 | -0.41 |
NETSOL Technologies | NTWK | Nov 27, 2024 | 2.68 | +0.75 |
Netstreit | NTST | Nov 27, 2024 | 16.32 | +0.62 |
Network-1 Technologies | NTIP | Nov 27, 2024 | 1.34 | +0.75 |
Neuberger Berman | NML | Nov 27, 2024 | 9.31 | +0.76 |
Neuberger Berman High Yield Strategies Fund | NHS | Nov 27, 2024 | 7.76 | +0.26 |
Neuberger Berman Municipal Fund | NBH | Nov 27, 2024 | 10.88 | +1.40 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Nov 27, 2024 | 13.13 | -0.23 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Nov 27, 2024 | 3.87 | +0.78 |
NeueHealth | NEUE | Nov 27, 2024 | 4.77 | -2.59 |
Neumora Therapeutics | NMRA | Nov 27, 2024 | 9.76 | -0.10 |
Neuraxis | NRXS | Nov 27, 2024 | 3.10 | +1.47 |
Neurobo Pharmaceuticals | NRBO | Nov 27, 2024 | 2.36 | +0.43 |
Neurocrine Biosciences | NBIX | Nov 27, 2024 | 126.59 | -1.03 |
Neurogene | NGNE | Nov 27, 2024 | 25.80 | -3.98 |
NeuroMetrix | NURO | Nov 27, 2024 | 4.30 | +1.24 |
Neuronetics | STIM | Nov 27, 2024 | 0.96 | +0.95 |
NeuroOne | NMTC | Nov 27, 2024 | 0.62 | -11.00 |
Neuropace | NPCE | Nov 27, 2024 | 10.25 | +0.49 |
NeuroSense Therapeutics | NRSN | Nov 27, 2024 | 0.93 | +3.31 |
Nevro | NVRO | Nov 27, 2024 | 4.58 | +6.02 |
New America High Income Fund | HYB | Nov 27, 2024 | 8.29 | +0.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.